It is known that MYC is a downstream effector of ERBB2 signaling [54], that MYC-amplification results in Aurora kinase- dependent growth [47], and that co-amplification of ERBB2 and MYC is a frequent event in cancer [55]. This evidence concerns the gene ERBB2 and cancer.